|
[1]
|
Serotonin and the CNS - New Developments in Pharmacology and Therapeutics
2022
DOI:10.5772/intechopen.96381
|
|
|
|
|
[2]
|
Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease
Journal of Medicinal Chemistry,
2021
DOI:10.1021/acs.jmedchem.1c00703
|
|
|
|
|
[3]
|
Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence
Pharmaceuticals,
2021
DOI:10.3390/ph14020148
|
|
|
|
|
[4]
|
Understanding the Molecular Basis of 5-HT4 Receptor Partial Agonists through 3D-QSAR Studies
International Journal of Molecular Sciences,
2021
DOI:10.3390/ijms22073602
|
|
|
|
|
[5]
|
Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease
Journal of Medicinal Chemistry,
2021
DOI:10.1021/acs.jmedchem.1c00703
|
|
|
|
|
[6]
|
Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists
Journal of Medicinal Chemistry,
2018
DOI:10.1021/acs.jmedchem.8b00457
|
|
|
|
|
[7]
|
Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists
Journal of Medicinal Chemistry,
2018
DOI:10.1021/acs.jmedchem.8b00457
|
|
|
|
|
[8]
|
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders
2017
DOI:10.1016/B978-0-12-802810-0.00006-4
|
|
|
|
|
[9]
|
Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy
Future Medicinal Chemistry,
2016
DOI:10.4155/fmc-2016-0103
|
|
|
|
|
[10]
|
A Further Decrease in the Catalyst Loading for the Palladium-Catalyzed Direct Intramolecular Arylation of Amides and Sulfonamides
Advanced Synthesis & Catalysis,
2015
DOI:10.1002/adsc.201401129
|
|
|
|
|
[11]
|
Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease
European Journal of Medicinal Chemistry,
2015
DOI:10.1016/j.ejmech.2015.08.051
|
|
|
|
|
[12]
|
A Further Decrease in the Catalyst Loading for the Palladium‐Catalyzed Direct Intramolecular Arylation of Amides and Sulfonamides
Advanced Synthesis & Catalysis,
2015
DOI:10.1002/adsc.201401129
|
|
|
|
|
[13]
|
Practical synthesis of 5-amino-6-chlorochroman-8-carboxylic acid – a key intermediate for several potent 5-HT4receptor agonists
Green Chemistry Letters and Reviews,
2014
DOI:10.1080/17518253.2014.904010
|
|
|
|